Wijeyaratne Serosha Mandika, Ubayasiri Ranjuka Arushana, Weerasinghe Charitha
University of Colombo, Department of Surgery, Kynsey Road, Colombo, 7, Sri Lanka.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.02.2009.1635. Epub 2009 Jul 14.
Embolotherapy of arteriovenous malformations (AVM) is not without risk. A 28-year-old woman underwent transcatheter selective embolisation of an AVM in the cheek using polyvinyl alcohol (PVA) microparticles. She became hypoxic and hypotensive post procedure, and had repeated cardiorespiratory arrests despite aggressive support. Resistant hypoxia with gross right heart dilatation on echocardiography suggested extensive pulmonary embolism. She died 24 h later. A postmortem confirmed widespread thrombosis and PVA particles in the pulmonary microvasculature identical to that in the treated AVM. This is the first reported death from PVA particle pulmonary embolism following therapeutic embolisation of a peripheral AVM.
动静脉畸形(AVM)的栓塞治疗并非毫无风险。一名28岁女性接受了经导管使用聚乙烯醇(PVA)微粒对脸颊部AVM进行的选择性栓塞。术后她出现低氧血症和低血压,尽管给予积极支持仍反复发生心肺骤停。超声心动图显示严重的右心扩张伴顽固性低氧血症提示广泛肺栓塞。她在24小时后死亡。尸检证实肺微血管系统广泛血栓形成且存在与治疗的AVM中相同的PVA微粒。这是首例报道的外周AVM治疗性栓塞后因PVA微粒肺栓塞导致的死亡。